Your browser is no longer supported. Please, upgrade your browser.
Settings
TXMD TherapeuticsMD, Inc. daily Stock Chart
TXMD [NYSE]
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-0.45 Insider Own21.84% Shs Outstand201.56M Perf Week-1.56%
Market Cap1.27B Forward P/E- EPS next Y-0.31 Insider Trans0.01% Shs Float159.47M Perf Month5.16%
Income-88.70M PEG- EPS next Q-0.11 Inst Own78.40% Short Float35.36% Perf Quarter15.54%
Sales18.30M P/S69.61 EPS this Y6.70% Inst Trans-5.23% Short Ratio22.52 Perf Half Y-4.39%
Book/sh0.46 P/B13.74 EPS next Y27.90% ROA-66.60% Target Price13.78 Perf Year-5.25%
Cash/sh0.48 P/C13.20 EPS next 5Y15.00% ROE-74.20% 52W Range3.50 - 8.30 Perf YTD9.53%
Dividend- P/FCF- EPS past 5Y-17.30% ROI-70.80% 52W High-23.81% Beta1.15
Dividend %- Quick Ratio7.70 Sales past 5Y56.10% Gross Margin82.00% 52W Low80.57% ATR0.34
Employees159 Current Ratio7.80 Sales Q/Q-2.30% Oper. Margin- RSI (14)51.78 Volatility5.07% 4.94%
OptionableYes Debt/Eq0.00 EPS Q/Q9.90% Profit Margin- Rel Volume0.64 Prev Close6.65
ShortableYes LT Debt/Eq0.00 EarningsAug 03 AMC Payout- Avg Volume2.50M Price6.32
Recom1.80 SMA200.64% SMA508.35% SMA20011.16% Volume1,596,904 Change-4.96%
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Nov-01-13Initiated Stifel Buy $8
Sep-19-17 08:00AM  TherapeuticsMD, FDA Review for TX-004HR is Upcoming, Stock Shows Momentum ACCESSWIRE
Sep-14-17 04:30PM  TherapeuticsMD Announces Submission of Additional Endometrial Safety Information to the New Drug Application for TX-004HR Business Wire
08:33AM  Options Traders Expect Huge Moves in TherapeuticsMD (TXMD) Stock Zacks
Sep-12-17 08:08AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Sep-06-17 06:55AM  TherapeuticsMD to Present at Two Upcoming Investor Conferences Business Wire
Aug-22-17 08:30AM  Implied Volatility Surging for TherapeuticsMD, Inc. (TXMD) Stock Options Zacks
Aug-18-17 08:25AM  TherapeuticsMD (TXMD) Catches Eye: Stock Moves 5.9% Higher Zacks
08:10AM  Today's Research Reports on Stocks to Watch: TherapeuticsMD Inc. and Horizon Pharma ACCESSWIRE
Aug-17-17 08:06AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit +5.56%
Aug-16-17 04:30PM  TherapeuticsMD Announces Publication of Manuscript on the Womens Health Initiative Observational Study of Vaginal Estrogen Use in Postmenopausal Women Business Wire
Aug-15-17 08:07AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Aug-14-17 08:06AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Aug-12-17 08:06AM  See what the IHS Markit Score report has to say about TherapeuticsMD Inc. Markit
Aug-11-17 08:07AM  IHS Markit Score Update: Rise in demand for ETFs holding TherapeuticsMD Inc is a positive for its shares Markit
Aug-10-17 04:05PM  TherapeuticsMD Provides TX-004HR Regulatory Update Business Wire
08:07AM  IHS Markit Score Update: Drop in demand for ETFs holding TherapeuticsMD Inc is a negative sign for its shares Markit
Aug-09-17 06:00AM  6 Small Cap Stocks to Beat This Aging Bull Market Investopedia
Aug-04-17 04:41PM  Edited Transcript of TXMD earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-03-17 04:05PM  TherapeuticsMD Announces Second Quarter 2017 Financial Results Business Wire -5.57%
11:00AM  Investor Network: TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Jul-25-17 01:50PM  ETFs with exposure to TherapeuticsMD, Inc. : July 25, 2017 Capital Cube
Jul-20-17 04:30PM  TherapeuticsMD to Host Second Quarter Financial Results Conference Call and Webcast on August 3 Business Wire
Jul-19-17 11:34AM  Oppenheimer Bullish on Bank of America Corp (BAC), CymaBay Therapeutics Inc (CBAY) and TherapeuticsMD Inc (TXMD); Heres Why SmarterAnalyst
Jul-17-17 03:04PM  Cantor Remains Bullish on TherapeuticsMD Inc (TXMD) as Investors Await Clarity on TX-004 SmarterAnalyst -6.57%
11:59AM  Why TherapeuticsMD Inc Is Getting Clobbered Motley Fool
06:55AM  TherapeuticsMD Provides TX-004HR Regulatory Update Business Wire
Jul-14-17 05:19PM  ETFs with exposure to TherapeuticsMD, Inc. : July 14, 2017 Capital Cube
Jul-12-17 08:20AM  Today's Research Reports on Stocks to Watch: TherapeuticsMD, Inc. and Moleculin Biotech, Inc. Accesswire
Jul-11-17 11:14AM  Why TherapeuticsMD Inc Is Soaring Today Motley Fool
Jul-07-17 09:39AM  TherapeuticsMD, Inc. breached its 50 day moving average in a Bearish Manner : TXMD-US : July 7, 2017 Capital Cube +8.91%
Jun-20-17 04:17PM  TherapeuticsMD, Inc. Value Analysis (NYSE MKT:TXMD) : June 20, 2017 Capital Cube
Jun-19-17 02:35PM  DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
10:13AM  DEADLINE TODAY: TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 GlobeNewswire
10:07AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017 Accesswire
08:39AM  Are Options Traders Betting on a Big Move in TherapeuticsMD (TXMD) Stock? Zacks
08:22AM  TherapeuticsMD, Inc. breached its 50 day moving average in a Bullish Manner : TXMD-US : June 19, 2017 Capital Cube
Jun-16-17 11:59PM  JUNE 19 DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire +19.42%
04:46PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TherapeuticsMD, Inc. of Class Action Lawsuit and Upcoming Deadline - TXMD PR Newswire
03:37PM  DEADLINE MONDAY: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 -- TXMD Accesswire
10:13AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017 Accesswire
Jun-15-17 03:25PM  MONDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
11:21AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. GlobeNewswire
Jun-14-17 04:09PM  5-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017 GlobeNewswire
Jun-13-17 01:09PM  UPCOMING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
11:30AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and Lead Plaintiff Deadline of June 19, 2017 -- TXMD Accesswire
Jun-12-17 04:23PM  7-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
12:10PM  TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 Accesswire
10:05AM  INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017 Accesswire
Jun-09-17 11:58PM  EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
10:58AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and Lead Plaintiff Deadline of June 19, 2017 -- TXMD Accesswire
10:30AM  June 19 Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit Against TherapeuticsMD, Inc. Business Wire
10:04AM  INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017 Accesswire
Jun-08-17 05:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against TherapeuticsMD, Inc. and Certain Officers TXMD GlobeNewswire
01:42PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
11:45AM  The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017 Accesswire
Jun-07-17 12:39PM  APPROACHING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
10:52AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) and Lead Plaintiff Deadline - June 19, 2017 Accesswire
10:37AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 - TXMD Accesswire
Jun-06-17 02:25PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
11:14AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of a Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and Sets Lead Plaintiff Deadline of June 19, 2017 - TXMD Accesswire
Jun-05-17 06:42PM  INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire -9.76%
01:46PM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017 Business Wire
Jun-02-17 11:48PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire
11:39AM  The Klein Law Firm Announces a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017 Business Wire
10:51AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) and Lead Plaintiff Deadline - June 19, 2017 Accesswire
May-31-17 04:09PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm Accesswire +8.07%
May-30-17 10:27AM  TXMD INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 Business Wire
May-27-17 12:00AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm GlobeNewswire
May-26-17 07:05PM  EQUITY ALERT: Levi & Korsinsky, LLP N Shareholders of a Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. Business Wire -6.79%
May-25-17 02:13PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm GlobeNewswire +9.77%
10:25AM  TXMD INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 Accesswire
May-24-17 02:50PM  IMPORTANT THERAPEUTICSMD, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Florida against TherapeuticsMD, Inc. GlobeNewswire
11:45AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. - Sets Lead Plaintiff Deadline of June 19, 2017 - TXMD Accesswire
10:50AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) and Lead Plaintiff Deadline: June 19, 2017 Accesswire
May-23-17 04:37PM  EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:30PM  TherapeuticsMD Announces Presentation at Jefferies 2017 Healthcare Conference on June 8 Business Wire
May-22-17 10:50AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and Sets Lead Plaintiff Deadline of June 19, 2017 - TXMD Accesswire
May-19-17 11:49PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:15AM  Blog Coverage: Shire's Stock Price Jumped on Positive Results in Hereditary Angioedema Treatment Accesswire
May-18-17 11:14AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. -- Sets Lead Plaintiff Deadline of June 19, 2017 -- TXMD Accesswire
08:53AM  Are Options Traders Betting on a Big Move in TherapeuticsMD (TXMD) Stock? Zacks
May-17-17 02:21PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:01PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. Business Wire
10:47AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) and Lead Plaintiff Deadline: June 19, 2017 Accesswire
May-15-17 09:00AM  The Klein Law Firm Announces a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017 GlobeNewswire
May-11-17 03:35PM  EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:30AM  TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 GlobeNewswire
May-10-17 04:30PM  TherapeuticsMD Announces Presentation at Bank of America Merrill Lynch 2017 Healthcare Conference on May 16 Business Wire
11:16AM  INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:14AM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. GlobeNewswire
11:08AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TherapeuticsMD, Inc. - TXMD PR Newswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline: June 19, 2017 GlobeNewswire
May-09-17 04:38PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In TherapeuticsMD, Inc. To Contact The Firm PR Newswire
02:00PM  TXMD INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 Accesswire
01:49PM  FDA Expresses Concern On TherapeuticsMD; Oppenheimer Downgrades Benzinga
08:00AM  Today's on Research Reports on Biotech Stocks to Watch: TherapeuticsMD and MannKind Accesswire
May-08-17 05:28PM  SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire -10.49%
12:50PM  Law Offices of Howard G. Smith Reminds TherapeuticsMD, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
12:30PM  TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 Business Wire
TherapeuticsMD, Inc. operates as a women's health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. Its pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen. The company markets its products primarily through a direct national sales force to health care providers in the OB/GYN market space. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson Tommy GDirectorAug 30Buy5.995,00029,950674,500Sep 01 05:24 PM